Showing results (101-110 of 220) with videos related to
Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Choleragen (cholera toxin): a bacterial lectinR L Richards, J Moss, C R Alving, et al.Lupus|February 20, 2010
Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupusZ Racz, E Nagy, L Rosivall, et al.Progress in Clinical and Biological Research|January 1, 1980
Liposomes as vehicles for vaccinesC R Alving, B Banerji, T Shiba, et al.Vaccine|August 26, 1999
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid AM Rao, G R Matyas, F Grieder, et al.International Journal of Immunopharmacology|January 1, 1989
Inhibition of interferon gamma-induced macrophage microbicidal activity against Leishmania major by liposomes: inhibition is dependent upon composition of phospholipid headgroups and fatty acidsM J Gilbreath, W E Fogler, G M Swartz, et al.Antimicrobial Agents and Chemotherapy|June 1, 1991
Differential inhibition of 2'-deoxycytidine salvage as a possible mechanism for potentiation of the anti-human immunodeficiency virus activity of 2',3'-dideoxycytidine by dipyridamoleS S Patel, J Szebeni, L M Wahl, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibitionM J Gilbreath, D L Hoover, C R Alving, et al.Biochimica Et Biophysica Acta|June 25, 1975
Vitamin A in liposomes. Inhibition of complement binding and alteration of membrane structureC R Alving, D H Conrad, J P Gockerman, et al.Antimicrobial Agents and Chemotherapy|December 1, 1986
Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeysJ D Berman, W L Hanson, W L Chapman, et al.Nature Medicine|December 2, 2000
Transcutaneous immunization: a human vaccine delivery strategy using a patchG M Glenn, D N Taylor, X Li, et al.Pageof 22